Reduced Left Ventricle Ejection Fraction (<50%)
1 clinical trials · Condition
◉ Watch Reduced Left Ventricle Ejection Fraction (<50%)
| Record | Firm | Date |
|---|---|---|
| Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP) (NCT01900600) | Virginia Commonwealth University | 2013-04-01 |
Track Reduced Left Ventricle Ejection Fraction (<50%) automatically
Every clearance here is in the API, with alerts when new ones post.